Novel strategies of protecting non-cancer cells during chemotherapy: are they ready for clinical testing?
作者信息
Darzynkiewicz Zbigniew
机构信息
Brander Cancer Research Institute and Department of Pathology, New York Medical College, Valhalla, NY 10595, USA.
出版信息
Oncotarget. 2011 Mar;2(3):107-8. doi: 10.18632/oncotarget.249.
Abstract
摘要
相似文献
1
Novel strategies of protecting non-cancer cells during chemotherapy: are they ready for clinical testing?化疗期间保护非癌细胞的新策略：它们准备好进行临床试验了吗？
Oncotarget. 2011 Mar;2(3):107-8. doi: 10.18632/oncotarget.249.
2
The pursuit of oncotargets through understanding defective cell regulation.通过理解细胞调节缺陷来寻找肿瘤靶点。
Oncotarget. 2010 Nov;1(7):544-551. doi: 10.18632/oncotarget.189.
3
Cancer therapeutics revisited; novel drugs targeting cell signalling pathways, genome wide association studies and other trials and tribulations.癌症治疗学再探讨；靶向细胞信号通路的新型药物、全基因组关联研究及其他试验与磨难。
Br J Clin Pharmacol. 2013 Sep;76(3):317-9. doi: 10.1111/bcp.12216.
4
DNA repair as treatment target.DNA修复作为治疗靶点。
Eur J Cancer. 2011 Sep;47 Suppl 3:S333-5. doi: 10.1016/S0959-8049(11)70192-7.
5
Gambogic Acid and inhibition of tumor growth: a close association.
Cancer Biother Radiopharm. 2014 Aug;29(6):265. doi: 10.1089/cbr.2012.1432.
6
Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.靶向癌症治疗；克服耐药性的纳米技术方法
Curr Med Chem. 2015;22(11):1335-47. doi: 10.2174/0929867322666150209151851.
7
Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing.癌症中的纤溶酶原激活物抑制剂-1：未来治疗测试的理论依据与见解
Cancer Res. 2015 Aug 1;75(15):2969-74. doi: 10.1158/0008-5472.CAN-15-0876. Epub 2015 Jul 15.
8
A review of the profile of endothelin axis in cancer and its management.内皮素轴在癌症中的特征及其管理的综述。
Crit Rev Oncol Hematol. 2014 Feb;89(2):314-21. doi: 10.1016/j.critrevonc.2013.08.011. Epub 2013 Sep 4.
9
Precision cancer medicine: where to target?精准癌症医学：靶向何处？
Acta Pharmacol Sin. 2015 Oct;36(10):1161-2. doi: 10.1038/aps.2015.93. Epub 2015 Sep 21.
引用本文的文献
1
Cytotoxic and Antiproliferative Effects of Preussin, a Hydroxypyrrolidine Derivative from the Marine Sponge-Associated Fungus KUFA 0062, in a Panel of Breast Cancer Cell Lines and Using 2D and 3D Cultures.海洋海绵共生真菌 KUFA 0062 来源的羟吡咯烷衍生物 Preussin 对一组乳腺癌细胞系的细胞毒性和抗增殖作用及其在 2D 和 3D 培养中的应用。
Mar Drugs. 2019 Jul 30;17(8):448. doi: 10.3390/md17080448.
2
Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.蛋白激酶A II-α型调节亚基调控前列腺癌细胞对紫杉烷治疗的反应。
Cell Cycle. 2014;13(20):3292-301. doi: 10.4161/15384101.2014.949501.
3
Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions.癌症及与年龄相关疾病的常见药物和治疗方法：对美国国立癌症研究所引发思考的问题给出新答案
Oncotarget. 2012 Dec;3(12):1711-24. doi: 10.18632/oncotarget.890.
4
Rapalogs in cancer prevention: anti-aging or anticancer?拉帕肽在癌症预防中的作用：抗衰老还是抗癌？
Cancer Biol Ther. 2012 Dec;13(14):1349-54. doi: 10.4161/cbt.22859. Epub 2012 Nov 14.
5
Wt p53 impairs response to chemotherapy: make lemonade to spare normal cells.野生型p53会削弱对化疗的反应：化不利为有利以保护正常细胞。
Oncotarget. 2012 Jun;3(6):601-7. doi: 10.18632/oncotarget.548.
6
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment.减少化疗中的副作用：顺铂治疗中蛋白激酶Cδ的故事
Oncotarget. 2012 Jan;3(1):107-11. doi: 10.18632/oncotarget.439. Epub 2012 Jan 31.
本文引用的文献
1
Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture.在细胞培养中探索对正常人类成纤维细胞和上皮细胞进行化疗的长期保护。
Oncotarget. 2011 Mar;2(3):222-33. doi: 10.18632/oncotarget.248.
2
Metformin induces both caspase-dependent and poly(ADP-ribose) polymerase-dependent cell death in breast cancer cells.二甲双胍诱导乳腺癌细胞发生 caspase 依赖性和多聚（ADP-核糖）聚合酶依赖性细胞死亡。
Mol Cancer Res. 2011 May;9(5):603-15. doi: 10.1158/1541-7786.MCR-10-0343. Epub 2011 Mar 21.
3
Metformin in prostate cancer: two for the price of one.二甲双胍在前列腺癌中的应用：一箭双雕。
Ann Oncol. 2011 Dec;22(12):2556-2560. doi: 10.1093/annonc/mdr037. Epub 2011 Mar 18.
4
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy.基于p53的环磷酰胺疗法中放线菌素D/VX-680极光激酶抑制剂组合的评估。
Oncotarget. 2010 Nov;1(7):639-650. doi: 10.18632/oncotarget.198.
5
Metformin and cancer: new applications for an old drug.二甲双胍与癌症：老药新用。
Med Oncol. 2012 Jun;29(2):1314-27. doi: 10.1007/s12032-011-9846-7. Epub 2011 Feb 8.
6
Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy.低剂量放线菌素D对p53通路的特异性激活：基于p53的环疗法新途径。
Cell Cycle. 2009 Sep 1;8(17):2810-8. doi: 10.4161/cc.8.17.9503. Epub 2009 Sep 13.
7
Imatinib and its successors--how modern chemistry has changed drug development.伊马替尼及其后续药物——现代化学如何改变药物研发。
Curr Pharm Des. 2009;15(2):120-33. doi: 10.2174/138161209787002933.
8
Why Iressa failed: toward novel use of kinase inhibitors (outlook).
Cancer Biol Ther. 2003 Mar-Apr;2(2):137-40. doi: 10.4161/cbt.2.2.286.
9
Cyclotherapy: protection of normal cells and unshielding of cancer cells.
Cell Cycle. 2002 Nov-Dec;1(6):375-82. doi: 10.4161/cc.1.6.259.
Zotero 插件